Rapid point-of-care detection of SARS-CoV-2 RNA with smartphone-based upconversion luminescence diagnostics
Biosensors and Bioelectronics · 2023-02 · 222 · 114987
DOI: 10.1016/j.bios.2022.114987 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biosensors and Bioelectronics, 2023-02. Verfasst von Menglin Song und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Applied Physics, The Hong Kong Polytechnic University, Kowloon, 999077, Hong Kong, China. Hauptthemen laut MEDLINE: COVID-19, Biosensing Techniques. Die Arbeit wurde bisher 31-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Accurate COVID-19 screening via molecular technologies is still hampered by bulky instrumentation, complicated procedure, high cost, lengthy testing time, and the need for specialized personnel. Herein, we develop point-of-care upconversion luminescence diagnostics (PULD), and a streamlined smartphone-based portable platform facilitated by a ready-to-use assay for rapid SARS-CoV-2 nucleocapsid (N) gene testing. With the complementary oligo-modified upconversion nanoprobes and gold nanoprobes specifically hybridized with the target N gene, the luminescence resonance energy transfer effect leads to a quenching of fluorescence intensity that can be detected by the easy-to-use diagnostic system. A remarkable detection limit of 11.46 fM is achieved in this diagnostic platform without the need of target amplification, demonstrating high sensitivity and signal-to-noise ratio of the assay. The capability of the developed PULD is further assessed by probing 9 RT-qPCR-validated SARS-CoV-2 variant clinical samples (B.1.1.529/Omicron) within 20 min, producing reliable diagnostic results consistent with those obtained from a standard fluorescence spectrometer. Importantly, PULD is capable of identifying the positive COVID-19 samples with superior sensitivity and specificity, making it a promising front-line tool for rapid, high-throughput screening and infection control of COVID-19 or other infectious diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Applied Physics, The Hong Kong Polytechnic University, Kowloon, 999077, Hong Kong, China.
- State Key Laboratory for Emerging Infectious Diseases, Department of Microbiology, LKS Faculty of Medicine, The University of Hong Kong, Pokfulam, 999077, Hong Kong, China.
- Department of Biomedical Engineering, The Hong Kong Polytechnic University, Kowloon, 999077, Hong Kong, China.
- Department of Applied Physics, The Hong Kong Polytechnic University, Kowloon, 999077, Hong Kong, China. Electronic address: jh.hao@polyu.edu.hk.
Zitieren
APA
Song, M., Wong, M. C., Li, L., Guo, F., Liu, Y., Ma, Y., Lao, X., Wang, P., Chen, H., Yang, M., & Hao, J. (2023). Rapid point-of-care detection of SARS-CoV-2 RNA with smartphone-based upconversion luminescence diagnostics. Biosensors and Bioelectronics, 222, 114987. https://doi.org/10.1016/j.bios.2022.114987
Vancouver
Song M, Wong MC, Li L, Guo F, Liu Y, Ma Y, et al. Rapid point-of-care detection of SARS-CoV-2 RNA with smartphone-based upconversion luminescence diagnostics. Biosensors and Bioelectronics. 2023;222:114987. doi:10.1016/j.bios.2022.114987
BibTeX
@article{Song2023,
author = {Song, Menglin and Wong, Man-Chung and Li, Lihua and Guo, Feng and Liu, Yuan and Ma, Yingjing and Lao, Xinyue and Wang, Pui and Chen, Honglin and Yang, Mo and Hao, Jianhua},
title = {Rapid point-of-care detection of SARS-CoV-2 RNA with smartphone-based upconversion luminescence diagnostics},
journal = {Biosensors and Bioelectronics},
year = {2023},
volume = {222},
pages = {114987},
doi = {10.1016/j.bios.2022.114987}
}
EUVIMED